In breast cancer, Muendlein et al. reported that in 164 consecutive white patients with HER2-positive breast cancer, carriers of the G-allele of MACC1 SNP rs1990172 showed increased risk for progression or death to event-free survival and overall survival after age and tumour stage was adjusted 24. This evidence concerns the gene ERBB2 and neoplasm.